|
| 38096371 | Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML. | Blood | 2024 |
| 36977823 | Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1. | Leukemia | 2023 |
| 36635503 | Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes. | | 2023 |
| 37055414 | Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. | Blood Cancer J | 2023 |
| 36922593 | The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. | Nature | 2023 |
| 36922589 | MEN1 mutations mediate clinical resistance to menin inhibition. | Nature | 2023 |
| 36727398 | Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures -ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model. | | 2023 |
| 37520776 | The MLL-Menin Interaction is a Therapeutic Vulnerability in -rearranged AML. | | 2023 |
| 34582559 | The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. | Blood | 2022 |
| 35534777 | IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. | Nat Cancer | 2022 |
| 35017466 | Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). | Blood Cancer J | 2022 |
| 34232981 | Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML. | Blood | 2021 |
| 33542482 | Menin is necessary for long term maintenance of meningioma-1 driven leukemia. | Leukemia | 2021 |
| 32589720 | Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. | Blood | 2020 |
| 32001657 | Therapeutic targeting of preleukemia cells in a mouse model of <i>NPM1</i> mutant acute myeloid leukemia. | Science | 2020 |
| 32333633 | Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium. | Pediatr Blood Cancer | 2020 |
| 31355641 | Discovery of Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 Using a Novel Growth-Based Protocol of Screening and Optimization in CONTOUR. | Journal of Chemical Information and Modeling | 2019 |
| 31821784 | A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia. | Cancer Cell | 2019 |
| 29567358 | Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial. | Ann Allergy Asthma Immunol | 2018 |
| 28528082 | Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor. | Bioorganic and Medicinal Chemistry | 2017 |
| 27599745 | Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core. | Bioorganic and Medicinal Chemistry Letters | 2016 |
| 27393460 | Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeys. | European Journal of Pharmacology | 2016 |
| 26990539 | Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist. | Journal of Medicinal Chemistry | 2016 |
| 26897089 | Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists. | Bioorganic and Medicinal Chemistry | 2016 |
| 25445047 | Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes. | European Journal of Pharmacology | 2015 |
| 24470465 | Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition. | Hypertension | 2014 |
| 22810003 | Regulation of sphingomyelin phosphodiesterase acid-like 3A gene (SMPDL3A) by liver X receptors. | Molecular Pharmacology | 2012 |
| 21741239 | Biphenyl/diphenyl ether renin inhibitors: filling the S1 pocket of renin via the S3 pocket. | Bioorganic and Medicinal Chemistry Letters | 2011 |
| 24900262 | Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility. | ACS Medicinal Chemistry Letters | 2011 |
| 21786805 | Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1. | Journal of Medicinal Chemistry | 2011 |
| 19959358 | Optimization of orally bioavailable alkyl amine renin inhibitors. | Bioorganic and Medicinal Chemistry Letters | 2010 |
| 20864344 | Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1. | Bioorganic and Medicinal Chemistry Letters | 2010 |
| 20064717 | Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design. | Bioorganic and Medicinal Chemistry Letters | 2010 |
| 19457666 | Design and optimization of renin inhibitors: Orally bioavailable alkyl amines. | Bioorganic and Medicinal Chemistry Letters | 2009 |
| 18582379 | Purification and characterization of recombinant human renin for X-ray crystallization studies. | BMC Biochemistry | 2008 |
| 17942478 | Cloning, characterization and site-directed mutagenesis of canine renin. | Journal of Biochemistry | 2007 |
| 16787263 | Development of inhibitors of the aspartyl protease renin for the treatment of hypertension. | Current Protein and Peptide Science | 2006 |
| 15294281 | Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293. | Protein Expression and Purification | 2004 |
| 11969190 | Development of a homogeneous, fluorescence resonance energy transfer-based in vitro recruitment assay for peroxisome proliferator-activated receptor delta via selection of active LXXLL coactivator peptides. | Analytical Biochemistry | 2002 |
| 10937713 | Solid-phase synthesis of an arylsulfone hydroxamate library. | Bioorganic and Medicinal Chemistry Letters | 2000 |
| 11126297 | Polymer-supported tetrafluorophenol: a new activated resin for chemical library synthesis. | | 2000 |
| 10475260 | Method to analyze collagenase and gelatinase activity by fibroblasts in culture. | In Vitro Cellular and Developmental Biology - Animal | 1999 |
| 10052961 | Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template. | Journal of Medicinal Chemistry | 1999 |
| 29711099 | Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design? | Angewandte Chemie - International Edition | 1998 |
| 9034191 | Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. | Nature | 1997 |
| 9042103 | Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). | Journal of Neuroimmunology | 1997 |
| 8605725 | Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis. | Clinical and Experimental Metastasis | 1996 |
| 8522351 | Monoclonal antibodies against human collagenase and stromelysin. | | 1995 |
| 7674932 | Defined substrate mixtures for mapping of proteinase specificities. | Methods in Enzymology | 1995 |
| 8278810 | Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. | Science | 1994 |